These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1408 related items for PubMed ID: 12629375

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.
    Jackson G, Montorsi P, Cheitlin MD.
    Urology; 2006 Sep; 68(3 Suppl):47-60. PubMed ID: 17011375
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.
    Circulation; 2007 Oct 02; 116(14):1555-62. PubMed ID: 17785618
    [Abstract] [Full Text] [Related]

  • 7. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction.
    Bocchi EA, Guimarães G, Mocelin A, Bacal F, Bellotti G, Ramires JF.
    Circulation; 2002 Aug 27; 106(9):1097-103. PubMed ID: 12196335
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A, Rohde LE, Colombo FC, Goldraich LA, Stein R, Clausell N.
    J Card Fail; 2008 Apr 27; 14(3):189-97. PubMed ID: 18381181
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure.
    Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M.
    Eur Heart J; 2002 May 27; 23(10):806-14. PubMed ID: 12009721
    [Abstract] [Full Text] [Related]

  • 17. The effects of sildenafil on ocular blood flow.
    Koksal M, Ozdemir H, Kargi S, Yesilli C, Tomaç S, Mahmutyazicioglu K, Mungan A.
    Acta Ophthalmol Scand; 2005 Jun 27; 83(3):355-9. PubMed ID: 15948790
    [Abstract] [Full Text] [Related]

  • 18. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients.
    Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM.
    Eur Heart J; 2008 Jul 27; 29(13):1681-7. PubMed ID: 18534975
    [Abstract] [Full Text] [Related]

  • 19. [Cardiopulmonary exercise capacity in adult patients with atrial septal defect].
    Suchoń E, Podolec P, Tomkiewicz-Pajak L, Kostkiewicz M, Mura A, Pasowicz M, Tracz W.
    Przegl Lek; 2002 Jul 27; 59(9):747-51. PubMed ID: 12632902
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.